Expert Opinion on Biological Therapy

Published by: Taylor & Francis Group  

People

  1. Dao
    Dao
  2. Grommes
    Grommes
  3. Scheinberg
    Scheinberg
  4. Cheung
    Cheung
  5. Rosenberg
    Rosenberg
  6. Sabbatini
    Sabbatini
  7. Salles
    Salles
  8. Slovin
    Slovin

Groups

  1. Department of Medicine (7)
  2. Hematologic Malignancies, Division of (5)
  3. Alan and Sandra Gerry Metastasis and Tumor Ecosystems Center (3)
  4. Center for Molecular Imaging and Biotechnology (CMIB) (3)
  5. GSK Faculty (3)
  6. Solid Tumor Oncology Division (3)
  7. Tow Center for Developmental Oncology (TCDO) (3)
  8. Adult Leukemia (2)
  9. Alumni (GSK) (2)
  10. Center for Hematologic Malignancies (2)
Search Within
Formats
  1. Journal Article (8)
  2. Review (3)
Groups
  1. Department of Medicine (7)
  2. Hematologic Malignancies, Division of (5)
  3. Alan and Sandra Gerry Metastasis and Tumor Ecosystems Center (3)
  4. Center for Molecular Imaging and Biotechnology (CMIB) (3)
  5. GSK Faculty (3)
  6. Solid Tumor Oncology Division (3)

More Groups

People
  1. Christian Grommes (2)
  2. David Scheinberg (2)
  3. Tao Dao (2)
  4. Aaron Chang (1)
  5. Claire Oh (1)
  6. Deborah Mulford (1)

More People

Years
  1. 2021 (2)
  2. 2020 (1)
  3. 2016 (1)
  4. 2014 (1)
  5. 2013 (2)
  6. 2012 (1)

More Years

Publishers
  1. Taylor & Francis Group (11)

Results (11)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Targeting nectin-4 by antibody-drug conjugates for the treatment of urothelial carcinoma
    Review

    Wong, J. L.; Rosenberg, J. E.
    Expert Opinion on Biological Therapy (2021)

    Fulltext@MSK | Save
  • Tafasitamab for the treatment of relapsed or refractory diffuse large B-cell lymphoma
    Review

    Salles, G.; Długosz-Danecka, M.; Ghesquières, H.; Jurczak, W.
    Expert Opinion on Biological Therapy (2021)

    Fulltext@MSK | Save
  • Immunotherapy for castration-resistant prostate cancer: Has its time arrived?
    Review

    Slovin, S. F.
    Expert Opinion on Biological Therapy (2020)

    Fulltext@MSK | Save
  • Opportunities and challenges for TCR mimic antibodies in cancer therapy
    Journal Article

    Chang, A. Y.; Gejman, R. S.; Brea, E. J.; Oh, C. Y.; Mathias, M. D.; Pankov, D.; Casey, E.; Dao, T.; Scheinberg, D. A.
    Expert Opinion on Biological Therapy (2016)

    Fulltext@MSK | Save
  • Bevacizumab for the treatment of high-grade glioma: An update after phase Ill trials
    Journal Article

    Khasraw, M.; Ameratunga, M.; Grommes, C.
    Expert Opinion on Biological Therapy (2014)

    Fulltext@MSK | Save
  • Therapeutic antibodies to intracellular targets in cancer therapy
    Journal Article

    Veomett, N.; Dao, T.; Scheinberg, D. A.
    Expert Opinion on Biological Therapy (2013)

    Fulltext@MSK | Save
  • Anti-programmed death-1 and anti-programmed death-ligand 1 antibodies in cancer therapy
    Journal Article

    Hamid, O.; Carvajal, R. D.
    Expert Opinion on Biological Therapy (2013)

    Fulltext@MSK | Save
  • Bevacizumab for the treatment of high-grade glioma
    Journal Article

    Khasraw, M.; Simeonovic, M.; Grommes, C.
    Expert Opinion on Biological Therapy (2012)

    Fulltext@MSK | Save
  • Abagovomab for ovarian cancer
    Journal Article

    Pfisterer, J.; Harter, P.; Simonelli, C.; Peters, M.; Berek, J.; Sabbatini, P.; du Bois, A.
    Expert Opinion on Biological Therapy (2011)

    Fulltext@MSK | Save
  • Monoclonal antibody therapies for solid tumors
    Journal Article

    Tassev, D.; Cheung, N. K. V.
    Expert Opinion on Biological Therapy (2009)

    Fulltext@MSK | Save

    • Expert Opinion on Biological Therapy – authorized name for:

    Name ISSN / ISBN Publisher
    Expert Opinion on Biological Therapy 1471-2598 Taylor & Francis Group
    Expert Opinion on Biological Therapy 1471-2598 Taylor & Francis Group
    Expert Opinion on Biological Therapy 1471-2598 Unknown
    Expert Opinion on Biological Therapy 14712598 Unknown
    Expert Opinion on Biological Therapy 1471-2598 Taylor & Francis Group
    Expert Opinion on Biological Therapy 1471-2598 Ashley Publications Ltd
    Expert Opinion on Biological Therapy 1471-2598 Informa Healthcare
    Expert Opinion on Biological Therapy 14712598 2020, © 2020 Informa Uk Limited, Trading As Taylor & Francis Group
    Expert Opinion on Biological Therapy 1471-2598 Taylor & Francis Group
    Expert Opinion on Biological Therapy 14712598 Informa Healthcare
    Expert Opinion on Biological Therapy 1471-2598 Taylor & Francis Group
    Expert Opinion on Biological Therapy 14712598 Ashley Publications Ltd
    Expert Opinion on Biological Therapy 14712598 Informa Healthcare